Table 8.
Tumor type | Search parameter | Number of cases | Average age, years | M:F | QNS % | Negative ( < 1%) | Expressed ( > 1%) |
---|---|---|---|---|---|---|---|
All cases | 850 | 69 | 441:409 | 6.2 | 68.4 | 25.4 | |
Lung | “NSCLC”a | 733 | 68 | 363:370 | 6.9 | 23.5 | 69.6 |
Breast | “breast” or “lobular” or [“ductal” not “pancreatic”] | 49 | 52 | 0:49 | 8.1 | 79.6 | 12.2 |
Esophagus | “esophagus” or “esophageal” or “GEJ” | 15 | 64 | 13:2 | 0 | 86.7 | 13.3 |
Adenocarcinoma | “adenocarcinoma” | 101 | 66 | 45:56 | 10.9 | 72.3 | 16.8 |
SCC | “squamous” or “SCC” or “SCCA” | 45 | 72 | 23:22 | 15.6 | 57.8 | 26.7 |
Metastatic | “metastatic” | 58 | 64 | 28:30 | 6.9 | 82.8 | 10.3 |
aIn contrast to other antibodies, NSCLC was indicated as a distinct parameter in database for SP142